Wednesday, December 3, 2025

Jim Cramer on New York Times: “I Like Their Case”

The New York Times Company (NYSE:NYT) is one of the stocks related to the AI space that Jim Cramer discussed. Cramer highlighted the company’s deals and ongoing lawsuit during the episode. He said:

“Who else could make out like a bandit by licensing their data to the big AI platforms? Hey, how about The New York Times? That’s the paper of record, for heaven’s sake. The New York Times has already begun to make some of these deals as well. In May, they announced a multi-year licensing agreement with Amazon that would allow Amazon to use their articles to train up AI models. I don’t know how much they’re getting, but the Gray Lady doesn’t need to spend an extra cent to make that money.

Stock market reports printed on a sheet of paper. Photo by RDNE Stock Project on Pexels

The New York Times Company (NYSE:NYT) produces and distributes news and information through digital, print, and audio platforms.

While we acknowledge the potential of NYT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.

Source link

Hot this week

Cosmo Shares Soar on Hair-Loss Treatment Results

Cosmo Pharmaceuticals NV shares soared the most in...

IronFX Celebrates 15 Years of Creating Strong Partnerships

Remaining ahead of the curve, year after year, in...

Inditex’s Sales Rise, Showing Retailer’s Resilience

Zara owner Inditex SA’s sales accelerated in November,...

Salesforce’s Stock Is Historically Cheap as AI Risk Takes a Toll

(Bloomberg) -- Salesforce Inc. shares have...

Desk-bound employees increasingly prone to frozen shoulder, say experts

Frozen shoulder -- medically known as adhesive capsulitis --...

Topics

Cosmo Shares Soar on Hair-Loss Treatment Results

Cosmo Pharmaceuticals NV shares soared the most in...

IronFX Celebrates 15 Years of Creating Strong Partnerships

Remaining ahead of the curve, year after year, in...

Inditex’s Sales Rise, Showing Retailer’s Resilience

Zara owner Inditex SA’s sales accelerated in November,...

Desk-bound employees increasingly prone to frozen shoulder, say experts

Frozen shoulder -- medically known as adhesive capsulitis --...

L’Oréal Will Start Work on Potential Armani Deal ‘Very Soon’, Says CFO

French cosmetics group L’Oréal will “definitely” look at...

Givaudan Acquires US Perfume Manufacturer Belle Aire Creations

Swiss fragrance maker Givaudan has acquired US fragrance...

Related Articles

Popular Categories

spot_img